These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26250622)

  • 1. Regional distribution of serotonergic receptors: a systems neuroscience perspective on the downstream effects of the multimodal-acting antidepressant vortioxetine on excitatory and inhibitory neurotransmission.
    Pehrson AL; Jeyarajah T; Sanchez C
    CNS Spectr; 2016 Apr; 21(2):162-83. PubMed ID: 26250622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
    Riga MS; Sánchez C; Celada P; Artigas F
    Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic Regulation of Prefrontal Cortical Circuitries Involved in Cognitive Processing: A Review of Individual 5-HT Receptor Mechanisms and Concerted Effects of 5-HT Receptors Exemplified by the Multimodal Antidepressant Vortioxetine.
    Leiser SC; Li Y; Pehrson AL; Dale E; Smagin G; Sanchez C
    ACS Chem Neurosci; 2015 Jul; 6(7):970-86. PubMed ID: 25746856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants.
    Pehrson AL; Sanchez C
    Drug Des Devel Ther; 2015; 9():603-24. PubMed ID: 25653499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters--a rat microdialysis and electrophysiology study.
    Pehrson AL; Cremers T; Bétry C; van der Hart MG; Jørgensen L; Madsen M; Haddjeri N; Ebert B; Sanchez C
    Eur Neuropsychopharmacol; 2013 Feb; 23(2):133-45. PubMed ID: 22612991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT
    Dale E; Grunnet M; Pehrson AL; Frederiksen K; Larsen PH; Nielsen J; Stensbøl TB; Ebert B; Yin H; Lu D; Liu H; Jensen TN; Yang CR; Sanchez C
    Brain Res; 2018 Jun; 1689():1-11. PubMed ID: 29274875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.
    Sanchez C; Asin KE; Artigas F
    Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.
    Bétry C; Pehrson AL; Etiévant A; Ebert B; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):1115-27. PubMed ID: 23089374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
    Bang-Andersen B; Ruhland T; Jørgensen M; Smith G; Frederiksen K; Jensen KG; Zhong H; Nielsen SM; Hogg S; Mørk A; Stensbøl TB
    J Med Chem; 2011 May; 54(9):3206-21. PubMed ID: 21486038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): modifying serotonin's downstream effects on glutamate and GABA (gamma amino butyric acid) release.
    Stahl SM
    CNS Spectr; 2015 Aug; 20(4):331-6. PubMed ID: 26062900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine may contribute to vortioxetine's procognitive effects; possibly through an orexigenic mechanism.
    Smagin GN; Song D; Budac DP; Waller JA; Li Y; Pehrson AL; Sánchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jul; 68():25-30. PubMed ID: 26945513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological properties of vortioxetine and its pre-clinical consequences].
    David DJ; Tritschler L; Guilloux JP; Gardier AM; Sanchez C; Gaillard R
    Encephale; 2016 Feb; 42(1 Suppl 1):1S12-23. PubMed ID: 26879252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo electrophysiological study of the targeting of 5-HT
    Schweimer JV; Brouard JT; Li Y; Sánchez C; Sharp T
    Eur J Neurosci; 2022 Mar; 55(6):1409-1423. PubMed ID: 35146812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of 5-HT₇ receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents.
    Westrich L; Haddjeri N; Dkhissi-Benyahya O; Sánchez C
    Neuropharmacology; 2015 Feb; 89():382-90. PubMed ID: 25446573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
    Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
    J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of time- and sex-dependent effects of vortioxetine on rat sexual behavior: Possible roles of direct receptor modulation.
    Li Y; Pehrson AL; Oosting RS; Gulinello M; Olivier B; Sanchez C
    Neuropharmacology; 2017 Jul; 121():89-99. PubMed ID: 28414050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex.
    Gasull-Camós J; Martínez-Torres S; Tarrés-Gatius M; Ozaita A; Artigas F; Castañé A
    Neuropharmacology; 2018 Sep; 139():41-51. PubMed ID: 29940206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons.
    Zhong P; Yan Z
    Neuroscience; 2004; 129(1):65-73. PubMed ID: 15489029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex.
    du Jardin KG; Müller HK; Sanchez C; Wegener G; Elfving B
    Eur J Pharmacol; 2016 Sep; 786():29-35. PubMed ID: 27235984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vortioxetine Treatment Reverses Subchronic PCP Treatment-Induced Cognitive Impairments: A Potential Role for Serotonin Receptor-Mediated Regulation of GABA Neurotransmission.
    Pehrson AL; Pedersen CS; Tølbøl KS; Sanchez C
    Front Pharmacol; 2018; 9():162. PubMed ID: 29559911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.